Viewing nowCombinationTelmisartan/Amlodipine/Atorvastatin Combined Tablet 80/5/5 mg
Telmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.

MFDS item code 202302811 · Approved 2023.09.25 · Insurance code 649808240
Treatment of hypertension, improvement of dyslipidemia, and inhibition of atherosclerosis progression and cardiovascular disease risk
This medication is used for patients with essential hypertension whose blood pressure is not sufficiently controlled with Telmisartan and Amlodipine combination. It also contains Atorvastatin Calcium, which helps patients with hypercholesterolemia and mixed dyslipidemia who cannot control their cholesterol levels by diet and exercise alone. It is particularly used as an adjunct to diet for patients with abnormal lipid levels due to family history and lowers total cholesterol and LDL cholesterol, delaying the progression of atherosclerosis. Additionally, it reduces the risk of various conditions such as stroke, myocardial infarction, and arterial revascularization in patients at high risk of cardiovascular disease. Patients taking this medication can simultaneously control their blood pressure and cholesterol levels, improving cardiovascular health.
Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking telmisartan/amlodipine combination therapy together with rosuvastatin as a single-ingredient product, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before starting the telmisartan/amlodipine combination, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 mg once daily. 2. Older adults: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients. In a drug interaction study of the active ingredients in this medicine, telmisartan/amlodipine 80/10 mg and rosuvastatin 20 mg, in the presence of telmisartan/amlodipine, rosuvastatin Cmax increased approximately 2.1-fold and AUC increased approximately 1.2-fold. Therefore, when administering this medicine, assess the potential risks associated with the increase in rosuvastatin Cmax and monitor patients closely.
This medication should not be used in pregnant women as it can cause serious harm to the fetus and newborn. If pregnancy is confirmed, take this medication immediately. Patients with allergies to any components or related components of this medication or those with certain hereditary diseases should not take it. In particular, patients with a history of angioedema, severe liver impairment, or severe kidney impairment may be at risk from using this medication. Elderly patients, those with hypotension, hyperkalemia, liver dysfunction, and similar conditions should use caution when administering this medication. Regular testing and monitoring are necessary as this medication can affect liver and kidney function. If symptoms such as muscle pain, muscle weakness, or muscle cramps occur during treatment, consult a physician immediately. If muscle-related problems are severe, discontinuation of the medication may be necessary. Interactions with other medications may occur, especially when taken with antihypertensives, diuretics, immunosuppressants, or certain antibiotics, so consultation with a physician is required. It is also recommended that breastfeeding women not use this medication, and if unavoidable, breastfeeding should be discontinued. In cases of overdose, hypotension, dizziness, and cardiac arrhythmias may occur, requiring immediate treatment. If an overdose is suspected, promptly visit a medical facility. This medication is not recommended for children and should be kept in a safe place out of reach of children.
Peripheral edema, dyspepsia, frequent bowel movements, diabetes, dizziness, dry vesicular sounds, urticaria, unstable angina, onychomycosis, lumbar spinal canal stenosis, ear discharge, vertigo, chronic gastritis, various gastrointestinal disorders, hiatal hernia, dysuria, rhinitis, discomfort in the oropharynx, pulmonary disease, unspecified gastrointestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory impairment, hyperkinesia, atherosclerosis, frequent urination, tinnitus, hearing loss, bad breath, fatty liver, upper respiratory infection, back pain, sinusitis, diarrhea, pharyngitis, influenza-like symptoms, dyspepsia, myalgia, urinary tract infection, abdominal pain, headache, dizziness, pain, fatigue, cough, hypertension, chest pain, nausea, vascular edema, fever, leg pain, lethargy, palpitations, dependent edema, angina, rapid pulse, leg edema, abnormal ECG, insomnia, drowsiness, migraine, paresthesia, involuntary muscle contractions, sensory impairment, flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, nonspecific gastrointestinal disease, gout, hypercholesterolemia, anxiety, depression, irritability, infection, fungal infection, abscess, otitis media, asthma, bronchitis, rhinitis, shortness of breath, nosebleeds, dermatitis, rash, eczema, itching, vascular edema, polymorphic erythema, rash, erythematous rash, papulovesicular rash, frequent urination, cystitis, leukopenia, purpura, thrombocytopenia, erectile dysfunction, thrombocytopenia, increased serum creatinine, acute kidney failure, oliguria, headache, dizziness, constipation, nausea, abdominal pain, itching, myalgia, myopathy, rhabdomyolysis, weakness, edema, facial edema, lower limb edema, vascular edema, hypersensitivity, increased sweating, erythema, chest pain, atrial fibrillation, congestive heart failure, elevated blood pressure, worsening hypertension, hypotension, hyperkalemia, hypoglycemia, syncope, muscle cramps, bradycardia, eosinophilia, increased uric acid, liver dysfunction, liver disease, anemia, elevated CPK, anaphylactic reaction, tendon pain, vasculitis, peripheral neuropathy, tremors, loss of appetite, dysphagia, pancreatitis, gingival hyperplasia, back pain, burning sensation, rigidity, weight gain, weight loss, sexual dysfunction, insomnia, abnormal dreams, depersonalization, shortness of breath, skin depigmentation, dry skin, hair loss, muscle weakness, single contraction, disordered coordination, hypertonicity, cool, moist skin, apathy, anxiety, amnesia, gastritis, increased appetite, loose stools, abnormal olfaction, taste disturbance, abnormal ocular motility, dry eyes, gynecomastia, jaundice, elevated liver enzyme levels, leukopenia, altered mental state, desquamative dermatitis, Stevens-Johnson syndrome, photosensitivity reaction, toxic epidermal necrolysis, polyneuropathy, amnesia, peripheral neuropathy, cough, shortness of breath, diarrhea, jaundice, hepatitis, increased transaminase levels, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, acute kidney failure, oliguria, thrombocytopenia, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication is packaged in special containers that block light and air. When stored, it should be kept at room temperature between 1 degree and 30 degrees Celsius, and it is important to avoid direct sunlight. This way, the medication's efficacy and safety can be maintained.
Oval two-layer tablet consisting of a white layer and a light blue layer
30 tablets/box [10 tablets/PTP x 3], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Myeong Mun Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.